HER-2 as a target for breast cancer therapy

Clin Cancer Res. 2009 Mar 15;15(6):1848-52. doi: 10.1158/1078-0432.CCR-08-1844.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Receptor, ErbB-2 / analysis
  • Receptor, ErbB-2 / antagonists & inhibitors*
  • Receptor, ErbB-2 / physiology
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab